These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15084580)

  • 21. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
    Tedesco D; Vesco C
    Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
    Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
    EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visualizing dynamic E2F-mediated repression in vivo.
    Agromayor M; Wloga E; Naglieri B; Abrashkin J; Verma K; Yamasaki L
    Mol Cell Biol; 2006 Jun; 26(12):4448-61. PubMed ID: 16738312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo structure of two divergent promoters at the human PCNA locus. Synthesis of antisense RNA and S phase-dependent binding of E2F complexes in intron 1.
    Tommasi S; Pfeifer GP
    J Biol Chem; 1999 Sep; 274(39):27829-38. PubMed ID: 10488129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation.
    White J; Stead E; Faast R; Conn S; Cartwright P; Dalton S
    Mol Biol Cell; 2005 Apr; 16(4):2018-27. PubMed ID: 15703208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression.
    Marlowe JL; Knudsen ES; Schwemberger S; Puga A
    J Biol Chem; 2004 Jul; 279(28):29013-22. PubMed ID: 15123621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis.
    Almasan A; Yin Y; Kelly RE; Lee EY; Bradley A; Li W; Bertino JR; Wahl GM
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5436-40. PubMed ID: 7777526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.
    Burkhart DL; Wirt SE; Zmoos AF; Kareta MS; Sage J
    PLoS Genet; 2010 Jun; 6(6):e1001003. PubMed ID: 20585628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
    Markey MP; Angus SP; Strobeck MW; Williams SL; Gunawardena RW; Aronow BJ; Knudsen ES
    Cancer Res; 2002 Nov; 62(22):6587-97. PubMed ID: 12438254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The histone deacetylase HDAC3 targets RbAp48 to the retinoblastoma protein.
    Nicolas E; Ait-Si-Ali S; Trouche D
    Nucleic Acids Res; 2001 Aug; 29(15):3131-6. PubMed ID: 11470869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
    Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
    Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site.
    Ouellette MM; Chen J; Wright WE; Shay JW
    Oncogene; 1992 Jun; 7(6):1075-81. PubMed ID: 1534398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family.
    Tevosian SG; Shih HH; Mendelson KG; Sheppard KA; Paulson KE; Yee AS
    Genes Dev; 1997 Feb; 11(3):383-96. PubMed ID: 9030690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD; Farlie PG; Watson RJ
    Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.